1. DOP41 Achievement of corticosteroid-free clinical endpoints in subjects with ulcerative colitis: an analysis of the phase 3 ELEVATE UC 52 trial. (30th January 2023) Authors: Sands, B E; Rubin, D T; Panés, J; Gecse, K B; Leung, Y; Goetsch, M; Wang, W; Shan, K; Woolcott, J; Smith, C C; Wosik, K; Schreiber, S W Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP59 Evaluation of the efficacy of tofacitinib as maintenance therapy in patients with Ulcerative Colitis stratified by OCTAVE Sustain baseline endoscopic subscore. (27th May 2021) Authors: Lee, S D; Allegretti, J R; Steinwurz, F; Connelly, S B; Lawendy, N; Paulissen, J; Gecse, K B Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hyperbaric oxygen therapy for the treatment of rectovaginal fistulas in patients with Crohn's disease: results of the HOT-REVA pilot study. Issue 3 (28th May 2021) Authors: Lansdorp, C A; Buskens, C J; Gecse, K B; D'Haens, G R A M; van Hulst, R A Journal: BJS open Issue: Volume 5:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP18 Efficacy and safety of filgotinib for the treatment of perianal fistulizing Crohn's Disease: Results from the phase 2 DIVERGENCE 2 study. (21st January 2022) Authors: Reinisch, W; Colombel, J F; D'Haens, G R; Rimola, J; DeHaas-Amatsaleh, A; McKevitt, M; Ren, X; Serone, A; Schwartz, D A; Gecse, K B Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i019 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P314 Microscopic appendicitis in ulcerative colitis: Feasibility of ultrasonographic diagnosis. (30th January 2023) Authors: Reijntjes, M; Pruijt, M; Visser, E; de Voogd, F; d'Haens, G R; Mookhoek, A; Gecse, K B; Buskens, C J; Bemelman, W A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P355 Motility in small bowel strictures in Crohn's Disease measured with cine-MRI. (30th January 2023) Authors: Beek, K; de Jonge, C S; van Rijn, K; de Voogd, F A E; Buskens, C J; D'Haens, G; Gecse, K B; Stoker, J Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P378 Rectal bleeding and stool frequency improvement with tofacitinib dose escalation to, 10 mg BID in patients with Ulcerative Colitis following loss of response on tofacitinib, 5 mg BID maintenance therapy: Results from OCTAVE Open. (21st January 2022) Authors: Allegretti, J R; Gecse, K B; Chiorean, M V; Argollo, M; Guo, X; Lawendy, N; Su, C; Mundayat, R; Paulissen, J; Salese, L; Irving, P M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P447 Early predictors of the need for surgery in patients with acute severe ulcerative colitis: results of the prospective, observational, international ESCP MASC study. (30th January 2023) Authors: Frasson, M; Pinkney, T; Gisbert, J P; Rodriguez-Lago, I; Blackwell, S; Gecse, K B; Buskens, C J; Knowles, C; Zmora, O; Brookes, M; Fiorino, G; Nos, P; Gallo, G; Pata, F; Verjee, A; Leone, S; Pellino, G Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P477 Rectal bleeding and stool frequency improvement with tofacitinib retreatment in patients with Ulcerative Colitis after treatment interruption: Results from OCTAVE Open. (21st January 2022) Authors: Allegretti, J R; Gecse, K B; Chiorean, M V; Argollo, M; Guo, X; Lawendy, N; Su, C; Mundayat, R; Paulissen, J; Salese, L; Irving, P M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P558 Etrasimod for the treatment of ulcerative colitis: analysis of infection rates from the phase 3 ELEVATE UC 52 and ELEVATE UC 12 clinical trials. (30th January 2023) Authors: Regueiro, M; Siegmund, B; Yarur, A; Steinwurz, F; Gecse, K B; Goetsch, M; Bhattacharjee, A; Wu, J; Green, J; McDonnell, A; Crosby, C; Lazin, K; Ferreira Branquinho, D; Modesto, I; Abreu, M T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗